In the UK, the progressive neurodegenerative condition affects around 153,000 people
News
Study reveals cardiovascular health could be biggest risk factor for dementia
Dementias, including Alzheimer’s disease, are estimated to affect 944,000 people in the UK
Study finds headache drug could prevent overuse of acute migraine medications
Chronic migraine is a neurological condition estimated to affect up to 2.2% of people globally
Researchers find whole genome sequencing improves care for paediatric cancer
Affecting around 3,755 young people in the UK every year, leukaemia is the most commonly diagnosed cancer in children
Female cancer survivors at low risk of developing obstetric complications
According to WHO, around 15% of pregnant women will develop an obstetric complication
University of Liverpool launches new biotech spin-out company Galytx
The biotech company will develop novel therapeutic drugs for the treatment of fatal diseases
ICL granted £150,000 to explore link between breast cancer and breastfeeding
Breast cancer is the most common cancer in the UK, accounting for 15% of all cancers
UK study reveals persistent challenges in heart health and cardiovascular diseases
The study found an increase in incidence among young people and people from deprived areas
Parkinson’s UK awards ICL £100,000 to develop small drugs for Parkinson’s disease
The neurodegenerative condition currently affects around 153,000 people in the UK
New collaboration aims to research early mutations in rare blood disorder
Langerhans cell histiocytosis currently affects around one in 200,000 children in the UK
UCL begins first UK deep brain stimulation study for children with rare epilepsy
Lennox-Gastaut syndrome affects up to 5% of children living with paediatric epilepsy
IHI’s new funding round to include topics on CVD and arthritis
The initiative’s proposals aim to tackle current challenges in health research and innovation
Researchers reveal how a protein interaction can increase Alzheimer’s risk
AD is the most common form of dementia, which affects over 944,000 people in the UK
Scientists uncover new disease-driving mechanism to treat atheroschlerosis
Atherosclerotic plaques in the arteries affect 42% of adults living without heart disease
Study shows cholesterol-lowering drug reduces diabetic retinopathy risk
An estimated 27% of patients globally living with diabetes will be affected by retinopathy
